Combivent® Respimat®
ipratropium bromide,
salbutamol, sulphate
About Combivent® Respimat®
A combination of a short-acting anticholinergic and beta-adrenergic for the management of reversible bronchospasms associated with obstructive airway diseases in patients requiring more than one bronchodilator.
Professional Area
You are a Healthcare Professional or Journalists & Media Professional? Click below to be able to see and access respective content.
Product Key Facts
Indications
Reversible bronchospasms associated with obstructive airway diseases
Brand Names
Combivent® Respimat®
Active ingredients
ipratropium bromide, salbutamol, sulphate